Maravai LifeSciences (MRVI) Q3 2024 Earnings Call Transcript
MRVI earnings call for the period ending September 30, 2024.
Maravai LifeSciences (MRVI) Q2 2024 Earnings Call Transcript
MRVI earnings call for the period ending June 30, 2024.
Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics
- Project Results in over 70% Reduction in Linea RNAP Manufacturing Cost to Yield a Material Improvement in Linea IVT Platform Profitability -- Applied DNA Secures Commercial Linea RNAP Quantity Sufficient...
Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics
- Project Results in over 70% Reduction in Linea RNAP Manufacturing Cost to Yield a Material Improvement in Linea IVT Platform Profitability -- Applied DNA Secures Commercial Linea RNAP Quantity Sufficient...
Maravai LifeSciences (MRVI) Q1 2024 Earnings Call Transcript
MRVI earnings call for the period ending March 31, 2024.
Maravai LifeSciences (MRVI) Q4 2023 Earnings Call Transcript
MRVI earnings call for the period ending December 31, 2023.
Maravai LifeSciences (MRVI) Q3 2023 Earnings Call Transcript
MRVI earnings call for the period ending September 30, 2023.